logo

GOSS

Gossamer Bio
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

GOSS fundamentals

Gossamer Bio (GOSS) expects to report earnings on Aug 11, 2025, with estimated revenue of 4.12M (YoY -95.70%), and EPS at -0.18 (YoY -181.82%).
Revenue estimate / YoY
4.12M
-95.70%
EPS estimate / YoY
-0.18
-181.82%
Report date
Aug 11, 2025
EPS
Revenue

Revenue & Expenses

GOSS has released its 2025 Q1 earnings report, with revenue of 9.89M, reflecting a YoY change of NaN%, and net profit of -36.64M, showing a YoY change of 12.62%. The Sankey diagram below clearly presents GOSS's revenue sources and cost distribution.

Key Indicators

Gossamer Bio (GOSS) key financial stats and ratios, covering profitability, financial health, and leverage.
Gossamer Bio (GOSS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gossamer Bio (GOSS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gossamer Bio (GOSS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gossamer Bio (GOSS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gossamer Bio (GOSS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield